Literature DB >> 15668895

Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions.

Khadijeh K Azar1, Mayuko Tani, Hideyo Yasuda, Akemi Sakai, Masaki Inoue, Toshiyuki Sasagawa.   

Abstract

Cytokines are released in response to infection of the uterine cervix by high-risk HPV. By using enzyme-linked immunosorbent assay, we measured the levels of tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (INF-gamma), interleukin-6 (IL-6), and interleukin-10 (IL-10) in the cervical secretions of 120 cytologically normal or equivocal and 91 abnormal Japanese women. HPV infection of the cervical cells was typed by the LCR-E7 PCR method. The HPV DNA-negative samples were classified as either normal or inflamed, and the HPV DNA-positive samples were classified as HPV positive(+) n-ormal and as low- or high-grade squamous intraepithelial lesions (SILs). Compared with the normal cervices, all of the cytokines tested were elevated in inflamed, HPV+ normal, low-grade SILs (LSIL), and high-grade SILs (HSIL). The level of IL-10 was statistically higher in LSIL, and the level of TNF-alpha was higher in HSIL, relative to the cytokine levels in the inflamed and HPV+ normal samples (P <0.05; Mann-Whitney test). Multivariate analyses confirmed that increased levels of IL-10 were associated with LSIL (relative risk [RR]=3.9, 95% confidence interval [CI]=1.7-8.8) and that increased levels of TNF-alpha (RR=4.6, 95% CI=1.4-15) and age older than 40 years (RR=8.5, 95% CI=1.3-56) were associated with HSIL. The levels of INF-gamma and TNF-alpha (Th1-cytokines) correlated negatively with those of IL-6 and IL-10 (Th2-cytokines) in HPV+ normal and LSIL subjects, whereas no such correlation was observed for HSIL. The up-regulated secretion of IL-10 may inhibit immune responses against HPV infection in early cervical lesions, whereas up-regulated TNF-alpha and uncoordinated cytokine secretion (elevated both Th1 and Th2 cytokines) may reflect impaired or invalid responses in advanced stage lesions. The detection of IL-10 and TNF-alpha in cervical secretions may be a useful indicator of local immune responses and of the stage of the cervical lesions induced by HPV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15668895     DOI: 10.1016/j.humpath.2004.08.012

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  24 in total

Review 1.  Early Defensive Mechanisms against Human Papillomavirus Infection.

Authors:  Andrea Moerman-Herzog; Mayumi Nakagawa
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

Review 2.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

3.  A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh.

Authors:  Wei Jie Seow; Wen-Chi Pan; Molly L Kile; Lin Tong; Andrea A Baccarelli; Quazi Quamruzzaman; Mahmuder Rahman; Golam Mostofa; Muhammad Rakibuz-Zaman; Muhammad Kibriya; Habibul Ahsan; Xihong Lin; David C Christiani
Journal:  Cancer       Date:  2015-03-10       Impact factor: 6.860

4.  Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.

Authors:  Qinghua Feng; Huafeng Wei; Janice Morihara; Joshua Stern; Mujun Yu; Nancy Kiviat; Ingegerd Hellstrom; Karl Erik Hellstrom
Journal:  Gynecol Oncol       Date:  2012-07-22       Impact factor: 5.482

5.  Evaluation of a multiplex panel of immune-related markers in cervical secretions: a methodologic study.

Authors:  Jill Koshiol; Martha Sklavos; Nicolas Wentzensen; Troy Kemp; Mark Schiffman; S Terence Dunn; Sophia S Wang; Joan L Walker; Mahboobeh Safaeian; Rosemary E Zuna; Allan Hildesheim; Ruth M Pfeiffer; Ligia A Pinto
Journal:  Int J Cancer       Date:  2013-07-30       Impact factor: 7.396

6.  Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth.

Authors:  Aline Bolpetti; João S Silva; Luisa L Villa; Ana Paula Lepique
Journal:  BMC Immunol       Date:  2010-06-07       Impact factor: 3.615

7.  Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma.

Authors:  Dae Woo Lee; Young Tae Kim; Sang Wun Kim; SungHoon Kim; Jae Hoon Kim; Myung Hwa Kang; Jeong Hye Hwang; Jong baeck Lim
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

8.  Anti-HE4 antibodies in infertile women and women with ovarian cancer.

Authors:  Ingegerd Hellstrom; Elizabeth Swisher; Karl Erik Hellstrom; Yuen Yee Yip; Kathy Agnew; Judith L Luborsky
Journal:  Gynecol Oncol       Date:  2013-05-28       Impact factor: 5.482

Review 9.  Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia.

Authors:  Kirvis Torres-Poveda; Margarita Bahena-Román; Claudia Madrid-González; Ana I Burguete-García; Víctor Hugo Bermúdez-Morales; Oscar Peralta-Zaragoza; Vicente Madrid-Marina
Journal:  World J Clin Oncol       Date:  2014-10-10

10.  Evaluation of mRNA expression levels of IL-17A and IL-10 cytokines in cervical cancer.

Authors:  Setareh Akhavan; Aghdas Safari; Sima Azizmohammadi; Susan Azizmohammadi; Maysam Aslami; Emad Yahaghi; Mehri Seifoleslami
Journal:  Tumour Biol       Date:  2016-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.